A study analysing cost and resource utilization in frail patients with overactive bladder treated with mirabegron or an antimuscarinic
Latest Information Update: 14 Jun 2021
At a glance
- Drugs Mirabegron (Primary) ; Muscarinic receptor antagonists
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Jun 2021 New trial record
- 15 May 2021 Results presented at the 2021 Annual Scientific Meeting of the American Geriatrics Society